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ABSTRACT 
NF-κB is a key regulator of innate and adaptive immunity and is implicated in the pathogenesis of 
acute kidney injury (AKI). The cell type-specific functions of NF-κB in the kidney are unknown; 
however, the pathway serves distinct functions in immune and tissue-parenchymal cells. We 
analyzed tubular epithelial-specific NF-κB signaling in a mouse model of ischemia-reperfusion injury 
(IRI)-induced AKI. NF-κB reporter activity and nuclear localization of phosphorylated NF-κB subunit 
p65 analyses in mice revealed widespread NF-κB activation in renal tubular epithelia and in 
interstitial cells following IRI that peaked at 2-3 days after injury. To genetically antagonize tubular 
epithelial NF-κB activity, we generated mice expressing the human NF-κB super-repressor IκBα∆N in 
renal proximal, distal, and collecting duct epithelial cells. These mice were protected from IRI-
induced AKI, as indicated by improved renal function, reduced tubular apoptosis, and attenuated 
neutrophil and macrophage infiltration. Tubular NF-κB-dependent gene expression profiles revealed 
temporally distinct functional gene clusters for apoptosis, chemotaxis, and morphogenesis. Primary 
proximal tubular cells isolated from IκBα∆N-expressing mice exposed to hypoxia-mimetic agent 
cobalt chloride were protected from apoptosis and expressed reduced levels of chemokines. Our 
results indicate that postischemic NF-κB activation in renal-tubular epithelia aggravates tubular injury 




Acute kidney injury (AKI) is common, affects >13 million people per year worldwide, and causes 
about 1.7 million deaths yearly.1, 2 Ischemia is frequently involved and an inflammatory response to 
sterile cell death or injury is common.3 The transcription factor NF-κB controls a large number of 
cellular processes, including immune and inflammatory responses, cell proliferation and migration, 
apoptosis and differentiation. The mammalian NF-κB family consists of five members p65 (RelA), c-
Rel, RelB, p50/p105 (NF-κB1), and p52/p100 (NF-κB2) that form various hetero- or homodimers.4 In 
the absence of any stimuli, NF-κB is sequestered in the cytoplasm by NF-κB inhibitors (IκBs). Specific 
stimuli lead to phosphorylation of IκB proteins by the IκB kinase complex (IKK), which results in 
ubiquitination and degradation of IκBs and subsequent translocation of NF-κB to the nucleus.4, 5 NF-
κB binds to specific sequences in the promoter or enhancer regions of target genes, which include 
genes encoding proinflammatory effectors as well as of IκB proteins to restore the steady state.6 The 
p65-p50 dimer (here referred to as NF-κB) is the heterodimer that is most frequently activated by a 
wide range of stimuli relevant to kidney injury, including cytokines and growth factors, pathogen-
associated damage and metabolic stress.7 Several approaches have previously been employed to 
elucidate the role of NF-κB in AKI, including an NF-κB decoy strategy in rat kidney allograft 
transplantation8 and rat renal ischemia reperfusion injury9, or systemic administration of small-
interfering RNAs targeting RelB10 or IKKβ 11 in murine AKI models. However, NF-κB was inhibited in all 
cell types in these models, thereby providing only limited information about cell-specific NF-κB 
functions in the kidney during AKI. Previous studies in intestine and skin have highlighted the 
importance of distinguishing the effects of NF-κB in immune cells and in tissue parenchymal cells.12 
While NF-κB signaling is frequently pro-inflammatory13-15, intestinal epithelial-specific or 
keratinocyte-specific NF-κB inhibition also can promote repair, indicating a substantial complexity of 
the cell type-specific NF-κB functions.16, 17 
We aimed to determine the in vivo time course of NF-κB activation and its function in renal tubular 
epithelial cells during ischemic AKI. To assess the in vivo time course, we generated an NF-κB 
reporter mouse model in which the luciferase gene is controlled by NF-κB. Furthermore, a mouse 
model with tubule-specific NF-κB suppression was produced. In combination with in vitro studies 
using isolated primary proximal tubular cells we show that NF-κB plays an important role in 





In vivo NF-κB Activity After Ischemia-Induced AKI 
To assess the time course of NF-κB activation following IRI-induced AKI, we generated a transgenic 
mouse model expressing the luciferase gene under the control of NF-κB (κ-Luc). A gradually increased 
NF-κB activity was detected in κ-Luc mice after ischemia-induced AKI by measuring in vivo luciferase 
activity in the kidney (Figure 1A). NF-κB activation increased significantly 12 hours after ischemia, 
compared to sham-operated mice (Figure 1B). The peak of NF-κB activity was reached 2-3 days after 
ischemia and gradually decreased thereafter (Figure 1B). To define in which cell types NF-κB was 
activated, we stained uninephrectomized kidneys (as internal control) and kidneys after 24 hours of 
ischemia with an anti-phospho-S276-p65 (RelA) antibody to determine nuclear translocation of NF-
κB. In kidneys subjected to ischemic injury followed by 24 hours of reperfusion, widespread nuclear 
phospho-p65 staining was observed in most tubular epithelial cells as well as in interstitial cells, 
whereas cells of the contralateral control kidney were not stained (Figure 1C, D). 
 
Generation of a Genetic Mouse Model with Tubular Epithelial-Specific NF-κB Inhibition 
To address the role of renal tubular NF-κB signaling in ischemic AKI, we generated a mouse model 
with tubular epithelial-specific NF-κB suppression using the Cre-loxP technology. First, we mated 
Emx1-Cre mice (http://www.informatics.jax.org/allele/MGI:1928281) with Rosa 26 reporter (R26R) 
mice to generate Emx1Cre;R26R reporter mice expressing β-galactosidase in cells with Cre-mediated 
recombination.18 Immunofluorescence staining revealed β-galactosidase expression in proximal 
tubules labeled by aquaporin-1, in distal convoluted tubules positive for the sodium-chloride 
symporter solute carrier family 12 member 3, and in a subset of aquaporin-2-positive collecting duct 
cells (Figure 2A), but not in thick ascending limbs of Henle labeled by sodium-potassium-chloride 
cotransporter solute carrier family 12 member 2 or in the interstitium labeled by fibronectin and 
fibroblast specific protein (Supplemental Figure 1A). These data confirmed a specific activity of Emx1-
Cre in renal tubular epithelium. 
To suppress NF-κB activity in a tissue-specific manner, we used mice in which a floxed IκBαΔN (loxP-
IκBαΔN) construct is expressed under control of the ubiquitously active β-catenin (ctnnb1) locus 
(Figure 2B).19 The NF-κB super-repressor IκBαΔN lacks the N-terminal phosphorylation and 
ubiquitination sites of IκBα and is therefore rendered insensitive to degradation.19 Offspring of 
matings between Emx1-Cre and loxP-IκBαΔN mice bearing both the Emx1-driven Cre and one floxed 
IκBαΔN knock-in allele are referred to as Emx1-∆N (Figure 2A). Immunoblot with IκBα-specific 
antibody on kidney lysates confirmed expression of IκBαΔN in Emx1-∆N mice but not in controls 
(Figure 2C and Supplemental Figure 1B). To assess if the tubular expression of IκBαΔN reduces NF-κB 
activity in the kidney after ischemic AKI, kidney sections were stained with anti-phospho-S276-p65 
antibody (Supplemental Figure 1C). Twenty-four hours after ischemia, kidneys of Emx1-∆N mice 
showed significantly less nuclear P-p65 intensity in the cortex and in the medulla compared to 
kidneys of control mice (Figure 2D). A detailed analysis of NF-κB activity by P-p65 staining in the 
tubular nephron segments of injured control kidneys revealed a widespread nuclear P-p65 signal in 
segments of the nephron. In Emx1-∆N mice, P-p65 signal was reduced in proximal tubules, distal 
tubules and partly in collecting ducts (Supplemental Figure 2A). Conversely, this difference was not 
evident in thick ascending limb of Henle's loop, where Cre activity is absent (Supplemental Figure 
2B). Moreover, mRNA expression of IκBα (NFKBIA), a bona fide NF-κB target gene, was significantly 
reduced in Emx1-∆N kidneys when compared to controls (Figure 2E). 
 
Tubular Epithelial-Specific NF-κB Inhibition Attenuates Renal Damage after Ischemic AKI  
To examine the effects of suppressed tubular NF-ΚB activity on overall renal damage, we performed 
ischemic AKI studies in Emx1-∆N and control littermates. Emx1-ΔN mice showed a significantly lower 
elevation in serum creatinine levels 24 hours after ischemia compared to control mice (Figure 3A). In 
addition, renal mRNA levels and urinary protein levels of renal-damage marker, neutrophil 
gelatinase-associated lipocalin (NGAL), were significantly lower compared with control mice (Figure 
3B, C). To assess the degree of tubular injury, kidney sections were stained and examined by an 
experienced renal pathologist unaware of genotype. These histological analyses clearly indicated an 
amelioration of cortical tubular ischemic injury in Emx1-ΔN mice as they presented less tubular 
necrosis and less tubular lumen occluded with cellular debris in the cortex (Figure 3D). In addition, 
the tubular injury score showed more intense damage in control mice compared with Emx1-ΔN mice 
(Figure 3E). Additional analysis of the S3 segments of the proximal tubule, which are most susceptible 
to ischemic injury, showed similar differences (Supplemental Figure 3A, B). 
 
Reduced apoptosis and inflammation in Emx1-ΔN mice after Ischemic AKI 
AKI is associated with increased infiltration of monocytes/macrophages and neutrophils, which 
contribute to the proinflammatory response in early AKI.20 To detect neutrophil and macrophage 
recruitment in the injured kidneys, we performed immunostaining and subsequently counted-labeled 
infiltrating cells in the outer medulla. Neutrophil and macrophage infiltration was significantly 
reduced 24 hours after ischemia in kidneys of Emx1-ΔN mice, compared with control mice (Figure 4A-
D). 
Renal tubular epithelial apoptosis can initiate reperfusion-induced inflammation and subsequent 
tissue injury.21 As NF-κB plays an important role in apoptosis,22 we aimed to determine the number of 
apoptotic tubular cells in the injured kidneys of control and Emx1-ΔN mice. Interestingly, compared 
to injured kidneys of control mice, kidneys of Emx1-ΔN mice showed a decreased rate of apoptosis as 
visualized by TUNEL labeling 24 hours after ischemia (Figure 5A). Quantification by direct counting of 
TUNEL-positive tubular cells confirmed this observation (Figure 5B). 
 
The NF-κB-Dependent Gene Signature Following Ischemic AKI 
To further define the effect of reduced tubular NF-κB signaling in the kidney following ischemic AKI, 
we performed microarray analysis on kidney samples, which were obtained from Emx1-ΔN or control 
mice 24 hours after induction of ischemia. Volcano plot revealed 240 genes differentially 
downregulated and 250 genes differentially upregulated in kidneys of Emx1-ΔN mice, compared to 
controls (fold change ≥ 1.2 and P<0.05, Figure 6A). Gene-set enrichment analysis23 confirmed a highly 
significant overrepresentation of known NF-κB target genes within downregulated genes 
(Supplemental Figure 4A). 
CD14 is a surface antigen preferentially expressed on monocytes/macrophages. The heterodimer, 
calprotectin (S100A8/A9), which has a wide plethora of intra- and extracellular functions colocalizes 
with Ly6G-positive neutrophils in AKI.24 The mRNA levels of these proteins were significantly less 
expressed in injured kidneys of Emx1-ΔN mice compared to controls (Figure 6B). Moreover, gene 
expression of vascular cell adhesion molecule (VCAM) 1, as well as of the pro-inflammatory cytokines 
(interleukin (IL)-1β and IL-6) and chemokines (chemokine (C-X-C motif) ligand) (CXCL) 1 and CXCL2, 
were significantly reduced in injured kidneys of Emx1-ΔN mice compared with controls (Figure 6B). 
For a more detailed investigation of the dynamics of the gene regulatory network governed by NF-κB, 
we analyzed gene expression at time points 6 hours, 24 hours, 48 hours, and 7 days after IRI-induced 
AKI in C57Bl/6J mice. We chose to restrict our analysis to differentially downregulated genes in 
Emx1-ΔN when compared to controls as they have shown enrichment for known NF-κB targets in 
Gene Set Enrichment Analysis (Supplemental Figure 4A). Most of these genes exhibited a transient 
peak expression at 6 hours after ischemia (Figure 6C, upper panel). However, when we performed a 
more detailed analysis of the gene expression time courses using k-means clustering and merging of 
similar clusters a posteriori, we found distinct subsets of genes with markedly different expression 
patterns (see Methods for a detailed description of the clustering analysis). The largest gene groups 
identified by this analysis comprised two gene sets, which we designated clusters 1 and 2 (Figure 6C, 
lower panels; see Supplemental Tables 2 and 3 for a full list of genes, clusters, and ontology terms). 
Cluster 1 peaked at 6 hours following AKI and quickly returned to baseline thereafter. This cluster 
contained genes mostly involved in apoptosis, cell death, and immune cell chemotaxis. Cluster 2 
displayed a delayed expression peak at 7 days and contained genes responsible for endocytosis, 
immune cell apoptosis, epithelial morphogenesis and wound healing. Hence, these findings suggest 
different time-dependent functions for NF-κB signaling following ischemic AKI in the kidney. 
Differentially expressed genes in the NF-κB signaling pathway from Kyoto Encyclopedia of Genes and 
Genomes (KEGG) are visualized on Supplemental Figure 4B. 
 
NF-κB Inhibition Leads to Reduced Apoptosis and Reduced Chemokine Expression Upon Cobalt 
Chloride (CoCl2) treatment in Primary Proximal Tubular Cells 
To differentiate between direct and indirect effects of tubular NF-κB signaling, we isolated proximal 
tubular epithelial cells from IκBαΔNubi mice and control mice. The stabilization of hypoxia-inducible 
factor (HIF)1α protein is a hallmark of hypoxia. To mimic hypoxia in vitro, cells were exposed to HIF1α 
stabilizing agent CoCl2 in a low glucose medium for 24 hours. We subsequently determined the 
percentage of apoptotic cells using Hoechst staining followed by fluorescent microscopy analyses 
(Figure 7A). Tubular cells expressing the NF-κB super-repressor IκBαΔN showed reduced apoptosis 
compared with control cells (Figure 7B). The mRNA expression of the HIF1α target gene vascular 
endothelial growth factor (VEGF) was upregulated by CoCl2 treatment in both groups (Figure 7C). 
CXCL1 and CXCL2 were only induced in control proximal tubular cells after CoCl2 treatment but not in 
cells expressing IκBαΔN (Figure 7D). Together, these data support a direct role of NF-κB signaling in 
tubular epithelial apoptosis and in the control of chemotactic cytokine expression by proximal 
tubules upon HIF1α stabilization. 
  
DISCUSSION 
We demonstrate that inhibiting NF-κB signaling in renal tubular epithelium reduces tubular injury, 
apoptosis, necrosis, and accumulation of interstitial inflammatory cells, which consequently results in 
ameliorated kidney damage after ischemic AKI induction. The treatment of primary proximal tubular 
cell cultures with hypoxia-mimetic agent CoCl2 further confirmed that reduced NF-κB activity per se 
reduces apoptosis and expression of certain chemokines. Previous work already implicated 
endothelial cell-specific suppression of NF-κB activity in the attenuation of hypertension-induced 
renal damage despite high blood pressure.25 Although endothelial NF-κB inhibition did not affect the 
development of hypertension, it diminished the upregulation of several proinflammatory NF-κB 
target genes including VCAM-1 and ICAM-1 and reduced renal inflammation and tubular damage. 
This state-of-affairs suggests that renal damage is, at least in part, dependent on NF-κB activity in 
vascular endothelial and tubular epithelial cells. NF-κB activity in these two compartments may be 
required for production of cytokines and chemokines and recruitment of immune cells. 
For the present study, we generated mice with suppressed NF-κB activity in the tubular epithelium 
(Emx1-∆N). To analyze the time course of NF-κB activation during ischemic AKI, for the first time we 
employed a luciferase-dependent in vivo imaging technique using an NF-κB reporter mouse model (κ-
Luc). Twelve hours after ischemic AKI induction, κ-Luc mice revealed a significant increase of NF-κB 
activity which lasted 5 days before it returned to base levels. Unfortunately, this technique does not 
allow us to differentiate between NF-κB activity derived from kidney cells or from infiltrating immune 
cells. However, phospho-p65 immunostaining showed an almost global increase of nuclear NF-κB 
activity in all renal compartments 24 hours following ischemic AKI induction, which suggests that a 
considerable amount, if not the majority of NF-κB-induced luciferase activity stems from kidney cells.  
Consistent with previous studies using global NF-κB silencing in different AKI models by injecting 
p105 or RelB silencing RNAs into the tail vein,10, 26 or by injecting NF-κB decoy oligodeoxynucleotides 
directly into the renal artery,8, 9, 11 we also observed reduced infiltration of neutrophils and 
macrophages in the injured kidneys of Emx1-∆N mice. Neutrophils and monocytes/macrophages 
respond rapidly to renal injury and play an important role in the deterioration of renal functions in 
AKI.27 However, the role of different macrophage subtypes in AKI and in subsequent repair and 
regeneration is currently explored.28 In our AKI model the mRNA levels of a classically activated 
macrophage marker, inducible nitric oxide synthase, and alternatively activated macrophage marker, 
interferon regulatory factor 4, were not significantly reduced in injured kidneys of mice with tubular 
IκBαΔN expression (Data not shown).  
Surprisingly, after ischemia we found less apoptosis in Emx1-ΔN mice compared with control mice. 
Although NF-κB is generally regarded as anti-apoptotic, in particular contexts and especially in 
response to cellular stress NF-κB can promote apoptosis.29 In line with this explanation, in proximal 
tubular cell cultures overexpressing IκBαΔN we found reduced apoptosis following hypoxia-mimetic 
CoCl2 treatment. Nevertheless, these results should be interpreted with caution. CoCl2 does not 
induce hypoxia, but instead activates hypoxia-mediated signaling pathways under normoxia by 
stabilizing the cytosolic HIF1α. Despite the pro-apoptotic effect of CoCl2 in our model, HIF1α can also 
exert anti-apoptotic effects30 and thus it may interfere with potential anti-apoptotic effects of NF-κB 
suppression. Complicating issues, IκBα has been reported to be a target of the HIF1α-regulating 
hydroxylase factor inhibiting HIF.31 Depite these caveats, the finding of reduced apoptosis in isolated 
proximal tubular cells overexpressing IκBαΔN  suggests that the reduced apoptosis rate represents a 
cell-autonomous effect of suppressed tubular NF-κB activity in renal tubules, which is independent 
from the tissue microenvironment and from inflammatory cell infiltrates. Inhibition of apoptosis 
induced by ischemia-reperfusion was previously shown to prevent inflammation.21 Therefore, the 
reduced apoptosis observed in Emx1-ΔN may also contribute to the reduced immune cell infiltration 
seen in these mice after ischemia.  
NF-κB regulates the expression of numerous genes, including cytokines/chemokines, cell adhesion 
molecules and stress response genes (http://www.bu.edu/nf-kb/). In the context of ischemic renal 
injury, several NF-κB-dependent target genes were also expressed in tubular cells.27, 32 Indeed, 
following induction of ischemic AKI kidneys of Emx1-ΔN mice showed significantly reduced 
expression of the murine homologues of human IL-8, CXCL1 and CXCL2, and IL-1β compared with 
control mice, which was verified in an in vitro model of chemical hypoxia in IκBαΔN-overexpressing 
primary proximal tubular cell cultures. This state-of-affairs indicates that tubular cells upregulate 
these molecules during ischemia and that their expression is dependent on NF-κB activity. A 
functional role for CXCL1 and 2 in AKI was further confirmed by a study demonstrating that 
treatment with an inhibitor of the CXCL1/CXCL2 receptor or with neutralizing antibodies against 
CXCL1 or CXCL2 during renal ischemia blocked interstitial neutrophil infiltration, reduced renal 
damage, and improved survival.33, 34 In addition, expression of VCAM1, which is induced on vascular 
endothelial cells by cytokine,35 was also significantly reduced in AKI-injured Emx1-ΔN kidneys, 
suggesting a crosstalk between tubular and endothelial cells. Supporting this notion, in the study by 
Henke and colleagues in which NF-κB was endothelial cell-specifically inhibited, tubular epithelial 
damage was also ameliorated.25 
Interestingly, a more detailed time-course-dependent comparison of differentially expressed genes 
between Emx1-ΔN and control kidneys revealed sets of genes, which could be assigned to distinct 
time-dependent functions. We show here that NF-κB is involved in regulating functional target gene 
programs including cell death, which peaks approximately 6 hours after AKI induction, while repair 
and morphogenesis pathways peak 7 days after ischemia. In summary, this finding suggests that 
persistent NF-κB activity results in time-dependent physiological changes in the kidney, which plays 
an important role in the development of AKI. 
NF-κB was initially identified as a transcription factor bound to the enhancer of the immunoglobulin 
kappa light chain gene in B lymphocytes.36 The omnipotence of NF-κB soon became clear, and many 
renal diseases have also been associated with impaired NF-κB activity.7, 37 Nevertheless, most of the 
evidence that links NF-κB activation to human and experimental kidney disease is descriptive, based 
on experiments with cell lines or performed in a way in which the effects of NF-κB modulation cannot 
be attributed to specific kidney cell types, which makes the physiological understanding of NF-κB in 
renal diseases difficult. However, we analyzed a mouse model with specific NF-κB suppression in the 
tubular epithelium. Using this mouse model we shed light on the importance of the tubular 
epithelium in the development of ischemic AKI. Our results may also help to understand the role of 






Transgenic mice expressing the luciferase gene under the control of NF-κB (κ-Luc, B6-Tg(κ-
Luc)1Gr/Rsu) carry 3 NF-κB DNA binding elements from the Igκ light chain enhancer hooked to the 
luciferase gene. The  luciferase reporter mice were generated based on the κ-Gal construct published 
earlier38 to non-invasively determine the in vivo pattern of NF-κB activity after induction of ischemia. 
Albino C57BL/6 mice were used to avoid quenching of luminescence. 
Mice with tubular cell–restricted NF-κB suppression were generated by mating Emx1-Cre knock-in 
mice (Emx1tm1.1(cre)Ito a generous gift from Shigeyoshi Itohara, RIKEN Brain Science Institute, 2-1 
Hirosawa, Wako City) with floxed IκBαΔN (loxP-IκBαΔN, B6.129P2-ctnnb1tm(NFKBIA∆Nfl/fl)Rsu) mice in which 
the cDNA of the human NF-κB super-repressor IκBαΔN was knocked into the β-catenin (Ctnnb1) locus 
(see Figure 2A).19 Offspring that did not express IκBαΔN (wildtype, Emx1-Cre or loxP-IκBαΔN mice) 
were used as controls. Emx1-ΔN mice developed normally, without any obvious phenotype. Kidneys 
of mice ubiquitously expressing the human NF-κB super-repressor IκBαΔN (IκBαΔNubi; B6.129P2-
ctnnb1tm(NFKBIA∆N)1Rsu) were used as positive control for Western blot analysis and for in vitro studies.19 
Emx1 promoter activity in the kidney was assessed by mating Emx1-Cre knock-in mice with Rosa 26 
reporter (R26R, B6;129S-Gtrosa26tm1Sor) mice.18 Emx1-Cre-mediated activation of β-galactosidase in 
the various kidney compartments was determined by using specific anti-β-galactosidase antibodies 
(detailed under Immunofluorescence). 
The Berlin Animal Review Board approved all protocols that were conducted to National Institute of 
Health Guide for the Care and Use of Laboratory Animals standards. 
 
In Vivo Renal Ischemia-Reperfusion Model 
 
Male mice between 12-15 weeks were used. Anesthesia was performed with isoflurane (2.3%) in air 
(350 ml/min). Each mouse was operated separately to ensure similar exposure to isoflurane (33±3 
minutes, mean±SD). A temperature controller with heating pad (TCAT-2, Physitemp Instruments) was 
used to keep body temperature stable at 37°C during surgery in order to induce warm ischemia. 
Rectal body temperature was continuously monitored using a sensor based on thermistors and 
values were recorded at different time points. Ischemia was induced after right-sided 
uninephrectomy by clipping the pedicles of the remaining left kidney for 17.5 minutes with non-
traumatic aneurysm clip (FE690K, Aesculap). Reperfusion was confirmed visually. After surgery, mice 
had free access to water and chow. We applied body-warm sterile physiological saline solution and 
analgesia with tramadol (1 mg/kg) for every mouse. Sham surgery was performed in a similar 
manner, except for clamping the renal vessels. Mice with bleeding after uninephrectomy, with 
incomplete renal reperfusion after ischemia, with excessive exposure of isoflurane of any reason, 
with significant temperature fluctuation during ischemia or with signs for infection after 24 hours 
were immediately killed and were not used for further analysis. After 24 hours of reperfusion mice 
were sacrificed, and kidney and blood was collected for further analysis. The kidneys were divided 
into three. One third of the kidney was placed in optimum cutting temperature (OCT) compound for 
immunohistochemistry, one third was immersed in 4% phosphate-buffered saline (PBS)-buffered 
formalin for histology and the rest was snap-frozen in liquid nitrogen for quantitative real-time (qRT)-
PCR.  
 
In Vivo Bioluminescence imaging of NF-κB Activity during Reperfusion 
 
Two days before bioluminescence imaging, mice were shaven dorsally at the sites of the kidneys to 
prevent any quenching of the bioluminescent signal by the fur. κ-Luc reporter mice were 
anesthetized with 2.5% isoflurane and injected subcutaneously with 1.5 mg D-luciferin (VivoGlo, 
Promega) in 100 μl PBS (pH 7.0). Whole-body image was acquired after an exposure time of 60 
seconds using an In Vivo Imaging System (IVIS Spectrum, PerkinElmer). Mice were measured at 
different time points after ischemia as depicted in Figure 1A. To obtain the luciferin kinetics, every 2 
minutes an image was acquired subsequently 10 times after D-luciferin injection. From the luciferin 
kinetics, the measurements showing maximal radiance were used for quantification. Using Living 
Image Software v4.2 (Caliper LifeSciences) the bioluminescent signal was quantified. Data are 
presented in physical units of radiance in photons/sec/cm2/steradian. 
 
Serum and Urine Measurements 
 
Blood samples were taken from left ventricle at termination. After clotting on room temperature for 
at least 15 minutes blood was centrifuged at 2,000×g for 10 minutes to obtain serum. Automated 
techniques were used to measure serum creatinine (Beckman Analyzer, Beckman Instruments). To 
assess basal laboratory parameters 100 μL blood was taken from facial region and parameters were 
measured using an i-STAT system with Chem8+ cartridges (Abbott). Urine sodium, creatinine was 
measured in 24-hour collected urine by Labor 28 (Berlin, Germany). Urine osmolarity of 24-hour 




Total RNA from snap-frozen kidneys and proximal tubular cells were isolated using RNeasy RNA 
isolation kit (Qiagen). RNA concentration and quality was measured by NanoDrop-1000 
spectrophotometer (Thermo Fisher Scientific). Two micrograms of RNA were used for cDNA 
transcription (Applied Biosystems). Quantitative analysis of target mRNA expression was performed 
with qRT-PCR using the relative standard curve method. TaqMan and SYBR green analysis was 
conducted using an Applied Biosystems 7500 Sequence Detector (Applied Biosystems). The 
expression levels were normalized to 18s. Biotez synthesized the primers and the sequences are 
provided in the in online supplement (Supplemental Table 1).  
 
Microarray and K-means clustering 
 
Total RNA isolated from kidneys as mentioned before were used for synthesis of cRNA by Illumina 
TotalPrep RNA Amplification kit (#AMIL1791, Thermo Fischer Scientific). The Illumina platform 
MouseWG-6 v2.0 Expression BeadChip Kit was used that assays more than 45,000 transcripts. Kits 
were used according to manufacturer's instruction. 
K-means clustering has been performed on the normalized gene expression data over time. That is, 
for each gene, we had 5 expression values corresponding to 0, 6, 24, 48 hours and 7 days. These 
values were normalized for each single gene such that the maximum over time corresponded to 1 
and the minimum to 0. These operations were performed for all genes separately. The normalized 
expression vectors were then clustered using k-means. For a k=20, 80% of the data's variance over 
time could be explained, thus, this k was chosen for clustering. The strongest clusters were then 
more closely investigated and were merged if they exhibited comparable patterns over time. These 




Kidney tissues were harvested from mice with different genotypes and were lysed with RIPA buffer 
(Sigma) supplemented with Complete Mini protease inhibitor (Roche), 1 mM phenylmethylsulfonyl 
fluoride (PMSF), Phosphatase inhibitor cocktail 3 (Sigma) and were homogenized using a Precellys 24 
homogenizator (Peqlab). Fifty μg protein samples were separated by 12% SDS-PAGE. After semi-dry 
transfer, non-specific binding sites of the nitrocellulose membrane were blocked with 5% non-fat 
milk in Tris-buffered saline containing 0.1% Tween (TBS-T). After that the membrane was incubated 
with the primary antibody against IκBα (1:200; sc-371 C-21, Santa Cruz). Secondary antibody was 
from LI-COR Biosciences (anti-rabbit, 1:5000). Images were acquired by Odyssey infrared imaging 
system (LI-COR Biosciences). 
Urine was collected from the bladder of mice subjected to ischemia 24 hours following surgery. Ten 
µl of urine were mixed with 4× non-reducing Nu-Page loading buffer (Invitrogen) and loaded on 
NuPage 4-12% Bis-Tris gel (Invitrogen). Afterwards, the proteins were blotted on a polyvinylidene 
fluoride membrane, which was further blocked in 5% non-fat milk in TBST for 1 hour at room 
temperature and then incubated overnight at 4°C with polyclonal anti-NGAL primary antibody 
(1:2000; #AF-1857, R&D Systems). Urinary NGAL was detected with horseradish peroxidase-
conjugated secondary antibody (1:5000; #705-035-147, Jackson ImmunoResearch.) and 
chemiluminescent reagent (Super Signal-West Pico, Thermo Scientific). Known amounts of 





We stained formalin-fixed, paraffin-embedded sections (2 μm) of kidneys with Masson's trichrome 
stain using standard protocols. The severity of tubular injury was assessed by a renal pathologist 
blinded to the genotype of the mice.  Tubular necrosis was evaluated in a semi-quantitative manner 
by determining the percentage of tubules in the cortex in which epithelial necrosis, loss of the brush 
border, cast formation, and tubular dilation was observed. A five-point scale was used: 0, normal 




Formalin-fixed, paraffin-embedded 2 μm thick sections were stained for S276 specific 
phosphorylated P-p65 (1:200; ab106129, Abcam). For visualization the EnVision+ Kit (Dako) was used 




For R26R mice 14 μm, in all other cases 5 μm thick cryosections were post-fixed in ice-cold acetone, 
air-dried, rehydrated and blocked with 10% normal donkey serum (Jackson ImmunoResearch) for 30 
min. Then sections were incubated overnight at 4°C with the following primary antibodies: rat anti-
F4/80 (1:200; MCA497; AbD Serotec), rat anti-Ly-6B.2 (Gr1) (1:300; MCA771G; AbD Serotec),  rabbit 
anti-aquaporin-1 (1:300; AB2219, Millipore), rabbit anti-sodium-chloride symporter (1:500; AB3553; 
Millipore), rabbit anti-aquaporin-2  (1:500; ab15116, Abcam), goat anti-aquaporin-2 (1:200, sc-9882; 
Santa Cruz Biotechnologies), mouse anti-FSP (1:250; F4771, Sigma), rabbit anti-fibronectin, (1:500; 
F3648, Sigma), rabbit anti-sodium-potassium-chloride cotransporter 2 (1:1000; a gift from Sebastian 
Bachmann, Charité Berlin), chicken anti-β-galactosidase (1:50; ab9361; Abcam)  and rabbit anti-S276 
P-p65 (1:200; ab106129, Abcam). All incubations were performed in a humid chamber.  For 
fluorescence visualization of bound primary antibodies, sections were further incubated with 
appropriate Cy3- or Alexa 488-conjugated secondary antibodies (1:500; Jackson ImmunoResearch) 




Formalin-fixed, paraffin-embedded 2 μm thick sections were labeled after pepsin-treatment with 
TMR In Situ Cell Death Detection Kit (Roche) according to the instructions of the manufacturer. Slides 
were counterstained with the nuclear dye 4’,6-diamidino-2-phenylindole (DAPI, Sigma) in order to 
visualize cell nuclei. Percentage of TUNEL-positive tubular cells was determined in the outer medulla 





Apoptosis assay was performed as described previously.39 Briefly, primary proximal tubular cells were 
plated onto poly-L-lysine coated glass coverslips and were cultured overnight. 24 hours later the 
medium was exchanged to fresh DMEM (Sigma) containing 1000mg/l glucose, 10% fetal calf serum 
(Biochrom) 10%, 100 IU/ml penicillin (Sigma) and 100 µg/ml streptomycin (Sigma). Cells were treated 
with 300 μM CoCl2  (Sigma) or kept untreated as described under the section "HIF1α Stabilization in 
Primary Proximal Tubular Cell". After 24 hours cells were fixed with 4% paraformaldehyde-containing 
PBS. Cell nuclei were stained with Hoechst 33342 fluorescent DNA-dye. Nuclear morphology of the 
samples was scored. At least 100-150 cell nuclei/sample were analyzed on randomly chosen view 
fields according to typical apoptotic nuclear morphology by Zeiss Axio Imager.M2 fluorescence 
upright microscope using 63× Plan-Apochromat immersion oil objective. 
 
Quantitative Digital Image Analyses 
 
All images were taken using a Zeiss Axioplan-2 imaging microscope with the computer program 
AxioVision 4.8 (Zeiss). Intensity of the staining of P-p65 was calculated as follows; for each analyzed 
picture, 10 randomly chosen nuclei were cut out manually, the rest of the image was deleted. Every 
pixel was then transformed into an RGB (red, green, blue) number triplet and normalized to length 1 
as we did not wish to measure brightness. The red channel count (RCC), as presented in the figures, is 
the value derived by # (pixels with entry >0.699 of the red channel in RGB after 
normalization)/#(pixels in the cut image). The threshold was derived from pixels of clear P-p65 
staining and the RCC is independent of image resolution. F4/80-positive and Gr1-positive cells were 
counted in 20 non-overlapping view fields in the cortex and the outer medulla at ×630 magnification. 
TUNEL-positive epithelial cells were counted at ×630 magnification in 5 non-overlapping outer 
medulla view fields and the numbers of positive cells were divided by the total cell number of that 
view field. 
 
Primary Proximal Tubular Cell Isolation 
 
Cells were obtained and cultured as described previously.40 Briefly, kidneys of IκBαΔNubi and 
littermate control mice aged 10-12 weeks were euthanized by overdose of isoflurane and flushed 
with 10 ml ice-cold PBS (Sigma) through left ventricle. Renal cortices were dissected visually and 
minced into small pieces. The fragments were transferred through two layers of stainless steel sieves 
(pore size 125 μm and 106 μm; Linker). Tubular fragments caught by the 106 μm sieve were flushed 
in the reverse direction with PBS and centrifuged for 5 minutes at 170×g, washed, and then 
resuspended into the appropriate amount of culture medium: 1:1 DMEM/F12 (D 8437; Sigma) 
supplemented with fetal calf serum (FCS) 10%, penicillin 100 IU/ml and streptomycin 100 µg/ml 
buffered to pH 7.4. Plate was incubated in a standard humidified incubator equipped with 5% CO2. 
Medium was changed two days later and maintained every other day until the monolayer of cells 
reached 90% confluence; at this time over 90% of the isolated cells were megalin-positive (sheep-
anti-LRP2 antibody (1:10000) was a gift from Prof. Thomas Willnow; secondary antibody was donkey 
anti-sheep Alexa 555 (1:2000; Thermo Fisher Scientific)). 
 
HIF1α Stabilization in Primary Proximal Tubular Cell 
 
Primary proximal tubular cells isolated from IκBαΔNubi and littermate control mice were treated with 
300 μm CoCl2 or left untreated in a low-glucose DMEM medium (D6046, Sigma) for 24 hours to 
stabilize HIF1α. Low glucose medium was used because it is known that cell death in proximal tubular 
cell cultures is HIF1α-dependent only when glucose availability is limited.41 Optimal concentration of 
CoCl2 and length of treatment were determined by preliminary experiments. After 24 hours medium 




Statistical analysis was performed using GraphPad 5.04 (GraphPad Software) and SPSS 13.0 (SPSS) 
software. Normality of the data was tested by Kolmogorov-Smirnov test. To test the presence of an 
outlier Grubbs' test was used. Mann-Whitney U test (data with non-normal distribution) or unpaired 
t-test (data with normal distribution) was used in case of 2 groups as stated in figure legends. In case 
of more than 2 groups data were analyzed by one-way ANOVA using Newman-Keuls post-hoc test. 
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Figure 1. Time course and localization of NF-κB activity in acute kidney injury. (A) In vivo 
bioluminescence whole-body imaging of κ-Luc mice following right uninephrectomy and sham 
surgery (control; upper panel) or 17.5 minutes left renal ischemia (lower panel). After the procedure, 
mice were imaged at time points stated below. (B) NF-κB-driven luciferase activity in sham operated 
mice (□, n=3) and in mice with ischemic kidney injury (■, n=4). *P<0.05, Student’s t-test. (C) 
Immunostaining of contralateral kidney (non-injured; left panel) and of kidney 24 hours after 
ischemia (injured; right panel) with an antibody against phosphorylated (P) p65. G, glomeruli; Pt, 
proximal tubule, Dt, distal tubule; Cd, collecting duct. Black frames indicate sites of ×400 
magnification. Yellow bars represent 1000 μm, black bars represent 50 μm. (D) Quantification of 
nuclear P-p65 staining in cortex (left panel) and medulla (right panel). RCC; red channel count (see 
Concise Methods). nContralateral=4, nInjured=4, #P<0.05, Mann-Whitney U-test. 
  
 
Figure 2. Generation and characterization of a mouse model with renal tubulus-specific expression of 
the human NF-κB super-repressor IκBαΔN. (A) Immunostaining on kidney sections from 
Emx1Cre;R26R mice using antibodies against β-galactosidase and aquaporin-1, sodium-chloride 
symporter or aquaporin-2 to verify renal tubular Cre activity. (B) The cDNA of the NF-κB super-
repressor IκBαΔN was knocked into the β-catenin (Ctnnb1) locus preceded by a loxP-stop-loxP 
cassette (loxP-IκBαΔN). Mating of loxP-IκBαΔN with Emx1-Cre knock-in animals generated mice 
expressing IκBαΔN only in cells with an active Emx1 promoter (Emx1-ΔN). (C) Verification of renal 
IκBαΔN expression in Emx1-ΔN mice by Western blotting using an anti-IκBα antibody. Kidney tissue 
lysates isolated from IκBαΔNubi mice, which constitutively express IκBαΔN ubiquitously, served as 
positive control. (D) Quantification of nuclear P-p65 staining in cortex (left panel) and medulla (right 
panel) from control and Emx1-ΔN mice 24 hours after ischemia. RCC, red channel count (see Concise 
Methods). ncontrol=4, nEmx1-ΔN=5, *P<0.05, Mann-Whitney U-test. (E) Expression of NFKBIA mRNA in 




Figure 3. Suppression of NF-κB activity in renal tubules ameliorates acute kidney injury. (A) Serum 
creatinine levels and (B) mRNA levels of kidney injury marker neutrophil gelatinase-associated 
lipocalin (NGAL) in Emx1-ΔN mice and control littermates 24-hours after ischemia. nControl=15, nEmx1-
ΔN=15, *P<0.05, Student’s t-test. (C) Urinary Western blot for analysis of NGAL expression using 
protein lysates from Emx1-ΔN mice and littermate controls. Recombinant mouse NGAL was used as a 
standard. nControl=3, nEmx1-ΔN=3, *P<0.05, Student’s t-test.  (D) Representative images of Masson's 
trichrome stain on kidney sections of controls and Emx1-ΔN mice after 24 hours of ischemia (×400). 
Tubular necrosis (×) and eosinophilic cellular debris (#) are shown. (E) Semi-quantification of cortical 
tubular injury. nControl=5, nEmx1-ΔN=5, *P<0.05, Student’s t-test. 
  
 
Figure 4. Inhibition of NF-κB activity in renal tubules is associated with reduced cellular infiltration 
after acute kidney injury. Immunofluorescence staining for neutrophil granulocyte marker Gr1 
(red,(A)) and for dendritic cell/macrophage marker F4/80 (red,(B)) on representative kidney sections 
of control and Emx1-ΔN  mice showing the outer medulla 24 hours after ischemia. Green staining is 
due to autofluorescence of tubules. Yellow bars represent 50 μm. Quantification of Gr1-positive (C) 
and F4/80-positive (D) cells. Each dot represents a single animal and is the mean of 20 randomly 
selected high-power fields (HPF). nControl=5, nEmx1-ΔN=5, *P<0.05, Student’s t-test.  
  
 
Figure 5. Inhibition of NF-κB activity in renal tubules leads to reduced apoptosis upon acute kidney 
injury. (A) Representative ×400 images of TUNEL labeling on control and Emx1-ΔN kidney sections 24-
hours after renal ischemia. Thin white arrows indicate TUNEL-positive tubular cells. Thick white 
arrows indicate TUNEL-positive interstitial cells. Yellow bars represent 50 μm. (B) TUNEL labeling was 
quantified by direct counting of the number of positively stained tubular cells that was divided by the 
total number of cells per x630 field. Each dot represents a single animal and is the mean of 5 
randomly selected outer medulla fields per animal. nControl=4, nEmx1-ΔN=4, *P<0.05, Student’s t-test. 
  
 
Figure 6. Microarray analysis comparing the gene expression profile of control versus Emx1-ΔN 
kidneys after ischemia. (A) Volcano plot for genes obtained from microarray analysis. Axes show 
logarithmic transformation of fold changes (x-axis) and P-values (y-axis). Genes differentially 
expressed (fold change>=1.2 and P-value<0.05) are in green if upregulated in Emx1-ΔN mice 
compared with controls, and in red if downregulated. (B) Verification by qRT-PCR of some of the NF-
κB target genes downregulated in injured Emx1-ΔN kidneys. (C) Time-dependent expression pattern 
of all genes downregulated in injured kidneys of Emx1-ΔN mice compared with controls (red dots in 
(A)) at 0, 6h, 24h, 48h and 7d after ischemia. Displayed are time points 0, 6h, 24h, 48h and 7d. The 
upper panel shows median and quartiles for all differentially expressed genes downregulated in 
Emx1-ΔN when compared to control while the lower two panels are result of k-means clustering of 
these genes with respect to their time-wise expression pattern (see Methods for details). For each 
cluster, the dominant gene ontology (GO) term from gene ontology analysis and representative class 
members is depicted (for a full list of all members of each cluster and detailed result of GO analysis 
see Supplemental Table 2 and 3). All gene expression values have been maximum normalized for 
each gene. 
 
Figure 7. Primary proximal tubular cells (PTC) overexpressing IκBαΔN show less apoptosis and 
reduced chemotactic cytokine expression after CoCl2 treatment. (A) Representative image of 
apoptotic PTC (white arrows) (x630). Yellow bar represents 50 μm. (B) Quantification of apoptotic 
PTC after a 24-hour treatment of 300 μM hypoxia-mimetic agent CoCl2. Data of two independent 
experiments. nControl=5, n IκBαΔN =6, *P<0.05, Student’s t-test. mRNA expression of (C) HIF1α target 
gene VEGFA, and (D) chemokine CXCL1 and CXCL2. Each dot represents a pool of PTC isolated from 2-
3 animals of the same genotype. Data of two independent experiments. nControl=6, n IκBαΔN =4, 
nControl+CoCl2=7 and n IκBαΔN+CoCl2=6. , #P<0.05 versus WT and IκBαΔN, &P<0.05 versus WT, IκBαΔN and 
IκBαΔN+CoCl2. One-way ANOVA, Newman-Keuls multiple comparison post-hoc test. 
